stonkbuilderCOMMUNITY NeuralinkHow to check clinical trials
Independent Research Notice: Independent StonkBuilder Community research publication. Not affiliated with, operated by, or endorsed by Neuralink Corp. or PreStocks. Neuralink devices are investigational and have not received FDA marketing authorization. Nothing here is medical, legal, or financial advice. PreStocks tokens are not Neuralink shares, confer no shareholder rights, and are unavailable to U.S. persons and residents of prohibited jurisdictions.

How to check Neuralink clinical trials and the official Patient Registry

Whether you are a patient, caregiver, clinician, or researcher, checking clinical trial information requires reading official study brochures and federal registry records directly. This five-step guide walks through how to inspect Neuralink's Patient Registry and ClinicalTrials.gov entries for PRIME (NCT06429735), CONVOY, and VOICE (NCT07224256)—and how to discuss trial participation with an independent physician.

NCT06429735PRIME Study IDQuadriplegia / computer control feasibility
NCT07224256VOICE Study IDSpeech restoration feasibility
US · CA · UK · UAERegistry regionsMulti-country clinical site footprint
100% FreeRegistry applicationReal clinical trials never charge application fees
Key points
  • This guide is for educational and research verification only and is never medical advice; always consult a qualified neurologist or neurosurgeon.
  • Neuralink's only official intake portal is the Patient Registry at neuralink.com/trials/ plus institutional clinical sites such as Barrow Neurological Institute.
  • Review the official PRIME Study Brochure PDF (neuralink.com/pdfs/PRIME-Study-Brochure.pdf) and ClinicalTrials.gov records NCT06429735 and NCT07224256.
  • Legitimate clinical trials never charge enrollment fees over social media or ask patients to buy crypto tokens.

Step-by-step workflow

  1. Step 1 of 5

    Start at neuralink.com/trials/ and read the official study brochures

    Navigate directly to https://neuralink.com/trials/ and https://neuralink.com/trials/speech-restoration/. Download the official PRIME Study Brochure PDF (https://neuralink.com/pdfs/PRIME-Study-Brochure.pdf), which explains what the study tests, the approximate multi-year follow-up schedule, and general eligibility.

    Verification check: Verify that the browser address bar shows neuralink.com over HTTPS before entering any personal health information.

  2. Step 2 of 5

    Compare the three active study tracks (PRIME, CONVOY, and VOICE)

    Identify which protocol matches the clinical question: PRIME evaluates N1/R1 safety and wireless computer control in quadriplegia (such as cervical spinal cord injury or ALS); CONVOY evaluates controlling an assistive robotic arm; VOICE evaluates speech decoding for severe communication impairment.

    Verification check: Each study has specific age, medical-stability, and anatomical inclusion and exclusion criteria.

  3. Step 3 of 5

    Inspect the federal registration on ClinicalTrials.gov

    Open https://clinicaltrials.gov/study/NCT06429735 (The PRIME Study) and https://clinicaltrials.gov/study/NCT07224256 (The VOICE Study). Review the 'Participation Criteria', 'Contacts and Locations', and 'Study Plan' sections.

    Verification check: ClinicalTrials.gov lists institutional clinical sites such as Barrow Neurological Institute in Phoenix, Arizona.

  4. Step 4 of 5

    Understand what joining the Patient Registry entails

    Submitting an application to the Neuralink Patient Registry (or an international registry in the US, Canada, UK, UAE, or global portal) does not automatically enroll a person in surgery. It initiates a pre-screening medical records review followed by formal informed-consent discussions with the study's clinical investigators.

    Verification check: Participation in any clinical trial is voluntary, and participants have the right to withdraw under informed-consent protections.

  5. Step 5 of 5

    Discuss benefits, surgical risks, and alternatives with an independent neurologist

    Before making any decision about an investigational Class III neurosurgical trial, review the full informed-consent packet with an independent physician who is not affiliated with the device sponsor.

    Verification check: Ask specifically about surgical risks, post-operative follow-up commitments, alternative assistive technologies, and long-term device management.

Clinical & Investigational Portfolio · Checked 30 Oct 2026 Separating PRIME, CONVOY, VOICE, and Blindsight by registry status and neural direction
PRIME · NCT06429735 Telepathy (Cursor) • Direction: Read (motor cortex) • Stage: Active human trial • Launched: 2023 (1st implant Jan '24) • Record: 11.32 BPS cursor control CONVOY STUDY Robotic Arm & Mobility • Direction: Read (motor cortex) • Stage: Active feasibility study • Launched: Nov 2024 • Demos: Arm (Oct '25), Chair (Jul '26) VOICE · NCT07224256 Speech Restoration • Direction: Read (speech motor) • Stage: Active human trial • Demos: Mar–Oct 2026 • Record: 75 WPM (5.8% WER, wk 1) BLINDSIGHT PROGRAM Cortical Vision (V1) • Direction: Write (microstimulation) • Stage: Preclinical / Breakthrough • FDA designation: Sep 2024 • Human data: None published yet
Overview of Neuralink's registered human clinical studies (PRIME, CONVOY, VOICE) and preclinical Blindsight.

In November 2025, Neuralink released a concise video overview explaining how its clinical trial team works with participants from registry screening through surgical recovery and home decoding:

Poster illustration for From Neural Signals To Life-Changing Impact | Neuralink
Official @neuralink Video 16 Apr 2026 · 2:47 Tier 1 · Multi-Study Clinical Overview
From Neural Signals To Life-Changing Impact | Neuralink

Click to load the privacy-enhanced youtube-nocookie.com player. No third-party cookies or requests are sent until you press play.

Watch on YouTube ↗ Read video analysis →
Source: Neuralink (@neuralink) · Channel UCLt4d8cACHzrVvAz9gtaARA · Video 8TX-HhtDD2U · Checked 30 Oct 2026 Direct YouTube link ↗Read video analysis →

Official November 2025 video ('An Introduction to the Neuralink Clinical Trials') outlining the PRIME, CONVOY, and VOICE clinical trial workflow.

ResourceVerified destinationPurpose
Neuralink Clinical Trials & Registryhttps://neuralink.com/trials/Official intake portal and study overview.
VOICE Speech Restoration Pagehttps://neuralink.com/trials/speech-restoration/Overview of the VOICE clinical trial.
PRIME Study Brochure (PDF)https://neuralink.com/pdfs/PRIME-Study-Brochure.pdfParticipant-facing brochure detailing PRIME study stages.
ClinicalTrials.gov: PRIMEhttps://clinicaltrials.gov/study/NCT06429735Federal protocol record for NCT06429735.
ClinicalTrials.gov: VOICEhttps://clinicaltrials.gov/study/NCT07224256Federal protocol record for NCT07224256.
Barrow Neurological Institutehttps://www.barrowneuro.org/patient-care/take-action/find-a-clinical-trial/clinical-trial/prime-study/Hospital clinical site page for the PRIME Study.

Sources checked 30 Oct 2026

Sources and official records

  1. [1] Neuralink: Clinical Trials and Patient Registry · Verified 30 Oct 2026
  2. [2] Neuralink: Speech Restoration (VOICE study overview) · Verified 30 Oct 2026
  3. [3] Neuralink: PRIME Study Brochure (PDF) · Verified 30 Oct 2026
  4. [4] ClinicalTrials.gov: The PRIME Study (NCT06429735) · Verified 30 Oct 2026
  5. [5] ClinicalTrials.gov: The VOICE Study for Communication Restoration (NCT07224256) · Verified 30 Oct 2026
  6. [6] Barrow Neurological Institute: PRIME Study Clinical Trial Information · Verified 30 Oct 2026
  7. [7] Neuralink YouTube (2026-04-16): From Neural Signals To Life-Changing Impact | Neuralink · Verified 30 Oct 2026
  8. [8] U.S. FDA: Implanted Brain-Computer Interface (BCI) Devices for Patients with Paralysis or Amputation · Verified 30 Oct 2026